Primary Job Title Chief Business Officer & COO Primary Organization Biothera
Location Greater Minneapolis-Saint Paul Area, United States, North America Gender Male
LinkedIn View on LinkedIn
Mr. Karel has extensive senior management experience in the research, development and commercialization of beta glucan and immunotherapy technologies. From 2003-2015, he was Chief Operating Officer responsible for all research and technology development for Immuno Research Inc. (formerly Biothera Inc.). During this period, the company grew its
research staff to over 25 scientists, filed over 20 patents, advanced an immunotherapy drug candidate into clinical trials for oncology which was subsequently licensed to Biothera Pharmaceuticals, Inc. Mr. Karel also was instrumental in the restructuring of the company’s businesses, including the sale of its immune health ingredient business and license of technology to Kerry Group PLC. In addition to his role as COO, Mr. Karel served as Chief Financial Officer at Immuno Research Inc. from 1998-2004. He has a bachelor’s degree in Accounting from the University of St. Thomas and began his career as a CPA with KPMG LLP.
